b-Catenin is an intracellular multifunctional protein. In complex with the transmembrane adhesive receptor Ecadherin, it becomes plasma membrane-associated and mediates intercellular adhesion. A cytosolic pool of b-catenin interacts with DNA-binding proteins and participates in signal transduction. To reveal the possible cross-talk between these two pools, we studied whether bcatenin is exchanged between its free and cadherin-bound states. We found that pulse-labeled b-catenin replaces the b-catenin bound to the cell surface prebiotinylated Ecadherin immediately after synthesis. Approximately 25% of all pulse-labeled b-catenin destined for E-cadherin associates with this protein via this mechanism. The rest of the newly synthesized b-catenin arrives at the plasma membrane in a complex with the E-cadherin precursor. Immediately after arrival, this b-catenin pool is transferred to the prebiotinylated E-cadherin. b-Catenin released from E-cadherin may participate in new exchange cycles. This b-catenin exchange is strongly affected in cells that contain mutations in the tumor suppressor gene APC. This process may contribute significantly to both cell-cell adhesion and b-catenindependent signaling.
Introduction
Classic and desmosomal cadherins are transmembrane adhesive receptors found in the diverse group of cell-cell junctions, collectively called adhering junctions (reviewed in Klymkowsky and Parr, 1995; Yap et al., 1997; Schmelz et al., 1998) . This group of junctions is responsible for tight but dynamic interactions between cells in tissue. A malfunction in these structures leads to major abnormalities in tissue morphogenesis and often results in tumor development. While different types of adhering junctions have well-defined individual features, they share some prominent molecular components. One of which is the presence of b-catenin and/or plakoglobin (g-catenin), two closely related proteins from the armadillo repeat gene superfamily, in their cytoplasmic face. These proteins link cadherins to the cytoskeleton via a diverse group of adapter proteins. a-Catenin is the major adapter protein that connects classic cadherinb-catenin/plakoglobin complexes to the cytoskeleton (Provost and Rimm, 1999) .
The interaction between cadherins and the cytoskeleton must be highly dynamic to allow cells to remodel their junctions with neighbors. Indeed, the direct fusion of Ecadherin to a-catenin compromises the motility of individual cells in the cellular monolayer (Nagafuchi et al., 1994) . The first evidence suggesting that catenins in a cadherin-catenin complex might be exchanged with new molecules recruited from the cytoplasm was obtained from pulse labeling experiments (Hinck et al., 1994) . Additional experiments showed that catenins could be dissociated from cadherin in response to certain stimuli. For example, b-catenin (Kinch et al., 1995; Balsamo et al., 1996) or a-catenin (Ozawa and Kemler, 1998) can be released from the complex with cadherin upon tyrosine phosphorylation. Alternatively, a-catenin can be displaced from the cadherin-catenin complex by the Rac1/ Cdc42 effector protein IQGAP1 (Kaibuchi et al., 1999) . It is still unclear whether catenin exchange is a continuous process or if it is induced only during specific morphogenetic events. The answer to this question is of major importance because catenin exchange may not serve merely to establish a dynamic link to the cytoskeleton, but catenins, and b-catenin in particular, released from cadherins may participate in signal transduction.
It is well documented that in addition to their role in adhesion, catenins are important signaling factors. In brief, b-catenin molecules that do not associate with cadherins are recruited into the b-catenin-destruction cytosolic complex containing the tumor suppressor gene product adenomatous polyposis coli (APC) (Bienz, 1999) . This complex triggers the ubiquitin-mediated bcatenin degradation. b-Catenin molecules that escape destruction, as well as cadherin complexes, heterodimerize with TCF/Lef transcription factor. Such heterodimers initiate the expression of several genes involved in cell proliferation and/or differentiation. During normal development, b-catenin degradation is regulated by extracellular proteins from the Wnt family. The unregulated increase of b-catenin levels, induced by mutations of APC or b-catenin itself, results in tumor development (Peifer and Polakis, 2000) .
Cadherin antagonizes catenin transcriptional activation (Heasman et al., 1994; Sanson et al., 1996; Orsulic et al., 1999) . Furthermore, cadherin-mediated suppression of b-catenin signaling is not accompanied by depletion of the b-catenin cytosolic level (Gottardi et al., 2001) . Based on this observation, it was suggested that in cytosol b-catenin is present in different functional pools. The signaling-competent pool of b-catenin is efficiently sequestered by cadherins. Considering catenin exchange process, however, one may suggest an alternative mechanism. By this mechanism, the cytosolic b-catenin pool is recruited, at least in part, from molecules released from cell-cell junctions. These molecules may have a modification making them incompatible with signaling activity. Therefore, cadherins could be efficient deactivators of b-catenin-mediated signaling by converting signaling-competent b-catenin into the inactive form.
To further our understanding of the catenin exchange process, we show here that catenins, immediately after synthesis, are targeted to cell surface-located cadherins, thereby replacing catenins in the pre-existing complexes. Released catenins may reassociate with other cadherin molecules. We also show that catenin exchange is strongly affected in tumor cells containing mutations in APC gene.
Results

Exchange of catenins in E-cadherin-catenin complex
Immediately after synthesis, the classic cadherin binds to either b-catenin or plakoglobin. Upon its arrival at the plasma membrane (it takes approximately 30 min in A-431 cells, our data unpublished) this dimer associates with a-catenin (Ozawa and Kemler, 1992; Hinck et al., 1994) . To determine whether catenins in the E-cadherincatenin complex are exchangeable, we monitored the incorporation of newly synthesized catenins into cell surface E-cadherin-catenin complex. A-431 cells were surface-biotinylated by a spacer arm cleavable Sulfo-NHS-SS-Biotin and then immediately pulse labeled with [ 35 S]methionine/cysteine. This subsequent labeling produced two separate 35 S-and biotin-labeled pools of proteins. At time 0 or after a 30-min chase, the cells were lysed and biotinylated proteins were pulled down by streptavidin-agarose. The proteins bound to the agarose were eluted by DTT and then immunoprecipitated with an anti-E-cadherin antibody, C20820 (Figure 1a ). This experiment showed that biotinylated E-cadherin, precipitated by such subsequent precipitations, interacted with The interval between surface-biotinylation and pulse labeling was either the same as in (a) (lane 0) or increased to either 1 (1) or 3 h (3) combined ( Figure 1a , lane C). This control confirmed a previous observation that catenins in complex with cadherin cannot be exchanged in vitro (Ozawa and Kemler, 1992) . As expected, the total amounts of immunoprecipitated E-cadherin or b-catenin was the same at all time points (Figure 1a ). The biotinylation was restricted to the surface proteins since catenins, after cell labeling, had no reactivity to streptavidin-peroxidase (not shown). Finally, when aliquots of the cell lysates were immunoprecipitated with an anti-b-catenin antibody (Figure 1b) , no increase in the intensity of the b-catenin band was observed after time 0, indicating that the pulse labeling was efficiently terminated.
The data described above show that newly synthesized catenins interact with E-cadherin present on the cell surface. While this observation implies that catenins in the complex with cadherin are exchangeable, two alternative possibilities were also considered. Our data may be explained by E-cadherin homodimerization.
Recently synthesized E-cadherin still lacking catenins escapes biotinylation because it is present in the transport compartment. It is associated with 35 S-labeled catenins and, after delivery to the cell surface, dimerizes with biotinylated E-cadherin. To exclude this possibility, we compared the association of 35 S-pulse-labeled catenins with biotinylated Ec1 M and Ec1WVM proteins ( Figure 1d ). A-431 cells stably producing these myc epitope-tagged E-cadherin mutants were described previously (Chitaev and Troyanovsky, 1998) . Ec1WVM, but not Ec1M, has a Trp156Ala mutation strongly reducing its homodimerization. Figure 1d shows that such a mutation did not affect the coprecipitation of the 35 S-labeled catenins. The second possibility is that a minor pool of E-cadherin may arrive at the cell surface in a catenin-free state. This hypothetical E-cadherin pool could coimmunoprecipitate the 35 S-labeled catenins. We tested this idea by varying the time intervals between biotinylation and pulse labeling. If an Ecadherin-catenin complex were to assemble at the cell surface, a significant reduction in the amount of 35 Slabeled catenin in the immunoprecipitates would be expected after extending the time interval between the two labeling procedures. However, no reduction was evident when the time period between biotinylation and pulse labeling was increased to 1 h or even to 3 h ( Figure 1e ).
Taken together, these experiments show that newly synthesized catenins can replace pre-existing catenins in the cadherin-catenin complex. The catenins released from E-cadherin may either replace catenins in other cadherin-catenin complexes or associate with other targets. Therefore, we examined whether a newly synthesized E-cadherin would associate with catenins released from the pre-existing cadherin-catenin complexes. We selected A-431 subclones expressing the Ec1WVM protein under a mifepristone-inducible promoter. These cells were first pulse labeled and then, after a 20 min lag period, mifepristone was added. Analysis of the total lysates showed that the Ec1WVM protein began to accumulate 2 h after induction and reached a plateau at approximately 4 h (Figure 2a) . The vast majority of this protein was unlabeled. Anti-myc immunoprecipitation, however, showed that this unlabeled Ec1WVM pool interacts with prelabeled catenins (Figure 2b ). This experiment utilizing standard anti-myc immunoprecipitation confirms the existence of the catenin exchange. Furthermore, these data imply that b-catenin can be relocated from one E-cadherin molecule to another.
Kinetics of catenin exchange
To approximate the rate of catenin exchange, we compared the fraction of pulse-labeled catenins associated with cell surface-located E-cadherin relative to those recruited into the complex with all (intracellular and surface-located) forms of E-cadherin. The cell lysate prepared at time 0 was split into two equal portions, which were immunoprecipitated with anti-E-cadherin mAbs, C20820 or SHE78-7. As we have previously shown ) the mAb SHE78-7 recognizes only fully processed, surface-located E-cadherin, while the mAb C20820 equally interacts with all E-cadherin forms. E-cadherin during a 10 min labeling period is unable to reach the cell surface and to be processed into the mature form (Ozawa and Kemler, 1992; Hinck et al., 1994) . In agreement with this, the SHE78-7 antibody did Figure 1 ) interact with the unlabeled Ec1WVM protein not precipitate pulse-labeled E-cadherin in our experiment (Figure 3a) . In contrast, the C20820 antibody precipitated the E-cadherin precursor (135 kD) and intermediate (115 kD) forms (Figure 3a , IP-C20820). Western blot analysis with the SHE78-7 antibody showed that both immunoprecipitates contained nearly the same amount of the unlabeled mature E-cadherin (Figure 3a, SHE) . Thus, with respect to E-cadherin, they differed only by the presence of unprocessed (intracellular) E-cadherin in the C20820 immunoprecipitate. Quantification of the catenin signals in both immunoprecipitates showed that nearly 80% of a-catenin and 25% of b-catenin/plakoglobin, which were all synthesized and associated with E-cadherin at time 0, associated with the fully processed form. These relatively high values indicate a high efficiency of the bcatenin/plakoglobin exchange process.
Next, we analysed the kinetics of the association of newly synthesized catenins with surface-located cadherin using biotin/ 35 S-labeled A-431 cells. Figure 3b shows that the incorporation of b-catenin into the complex can be divided into two distinct phases. During the first 20 min (phase 1), the amount of the labeled b-catenin in the complex gradually increased to approximately 50%. After 10 min, the amount of radiolabeled b-catenin in the complex with biotinylated E-cadherin nearly doubled (Figure 3c ) and then slowly declined (phase 2). The appearance of this peak coincides with the arrival of pulse-labeled E-cadherin to the surface. We propose that this peak represents the release of labeled b-catenin from the carrier E-cadherin molecules and their rebinding to surface-located E-cadherin. Consistent with this hypothesis, Brefeldin A, a potent inhibitor of intracellular trafficking, specifically affected the second phase of b-catenin-cadherin interactions. Importantly, the kinetics of a-catenin association with biotinylated E-cadherin were unchanged (Figure 3b) . Very similar kinetics of catenin exchange were obtained for EcWVM and Ec1 M (not shown).
b-Catenin exchange is independent of kinase inhibitors and the state of the cytoskeleton The Trp156Ala mutation, which affects E-cadherin adhesive activity (Chitaev and Troyanovsky, 1998), does not affect catenin exchange (Figure 1d ). Therefore, Figure 3 (a) Relative amounts of pulse-labeled catenins associated with all E-cadherin forms versus cell surface-located mature Ecadherin. A-431 cells grown on 3 cm dishes were pulse labeled and immediately extracted with 1.5 ml IP-buffer. The lysate was split into two equal portions which were immunoprecipitated with the antibodies C20820 (IP-C20820) or SHE78-7 (IP-SHE), which recognize either all forms or only the mature E-cadherin form, respectively. The immunoprecipitates were solubilized in 30 ml of SDS-sample buffer. The amounts of the immunoprecipitates loaded are indicated above the lanes. The autoradiogram ( 35 S) and Western blot stained with SHE78-7 antibody (SHE) are shown. The major precipitated proteins (E-cadherin precursor, Pr; E-cadherin intermediate form, In; a-catenin, a; b-catenin, b; and plakoglobin, g) are indicated by arrows. Note that the antibody C20820 (not the antibody SHE78-7) immunoprecipitates the E-cadherin precursor and intermediate forms. The SHE78-7 antibody, while unable to precipitate any 35 S-labeled E-cadherin forms, does coimmunoprecipitate 35 S-labeled catenins. SHE78-7 staining shows that both immunoprecipitates contained approximately equal amounts of the unlabeled mature E-cadherin. (b) Kinetics of association of newly synthesized catenins with surface-located Ecadherin. A-431 cells grown in the presence (+Brefeldin A) or in the absence (ÀBrefeldin A) of Brefeldin A were double labeled and processed as in Figure 1a . Intensities of b-catenin bands (indicated by arrow) in these blots were quantitated and plotted versus time. (c) Quantitative measurements of the b-catenin association with biotinylated E-cadherin were taken from five separate experiments and then normalized to 100% for the maximal association (at point 30 0 ). The means 7 s.e. from five individual experiments are shown this process is independent of the adhesive properties of E-cadherin. To examine whether catenin exchange is driven by reversible phosphorylation of the cadherincatenin complex, different protein kinase inhibitors (see the list of inhibitors in Materials and methods) were tested in our double-precipitation assay. The amount of the pulse-labeled catenins bound to biotinylated Ecadherin at time 0 and after 30 min of chase was determined for each set of inhibitors. However, we were unable to identify an inhibitor that detectably changed any of these parameters (not shown). Interestingly, LiCl, a potent inhibitor of the GSK-3b kinase, nearly doubled the total level of b-catenin and its lifetime, while not modifying the kinetics of b-catenin exchange (Figure 4 ). This indicates that cytosolic b-catenin, which is stabilized as a result of inhibiting GSK-3b kinase, does not compete with the newly synthesized protein for cadherin interaction.
We then studied whether catenin exchange is caused by a dynamic association of the cadherin-catenin complex with the cortical cytoskeleton. To address this issue, similar experiments as above were performed after adding potent inhibitors of actin polymerization, latrunculin A and cytochalasin D. Interestingly, while both inhibitors had a strong morphological effect on A-431 cells, no differences in the rate of exchange were observed (data not shown).
Catenin exchange is strongly affected in Colo 205 and HT-29 cells containing defects in the APS gene
The exchange of b-catenin and plakoglobin in complex with E-cadherin may be caused by the dynamic interactions between these two catenins with other adherens junction proteins. In addition to E-cadherin, b-catenin/plakoglobin interact with a-catenin and APC. To understand whether catenin exchange depends on these two proteins, we examined tumor cell lines containing defects in either a-catenin or APC genes. First, we compared the catenin exchange in a-catenindeficient MD-MBA-468 breast carcinoma cells and in the subclones of these cells producing recombinant a-catenin (484a cells). No significant difference in the b-catenin exchange between these cell lines was found (Figure 5a) .
We also analysed catenin exchange in APC-defective colon adenocarcinoma cell lines, Colo 205 and HT-29 containing a normal amount of E-cadherin and acatenins (Aono et al., 1999 and not shown). Relative to HT-29 and A-431 cells, Colo 205 cells have a significantly lower amount of plakoglobin and a slightly higher level of b-catenin (Figure 5b ). While the kinetics of association of pulse-labeled a-catenin with biotinylated E-cadherin were very similar in all cell lines, the binding of pulse-labeled b-catenin to surface-located Ecadherin was almost completely abolished in both adenocarcinoma cells (Figure 5c ). b-Catenin stabilization in APC-mutated cells is unlikely to be a reason for this loss of binding since (i) LiCl, even when added 6 h prior to labeling, did not affect catenin exchange (see above and not shown); and (ii) only in Colo 205, but not in HT-29 cells, was b-catenin significantly more stable than in A-431 cells (Figure 5c ). It is possible that the Colo 205-specific point mutation Gly245Ala of bcatenin (Ilyas et al., 1997) contributes to the additional stability of this protein. Taken together, our data indicate that APC function is inter-related with catenin exchange.
Discussion
In this paper we present clear experimental evidence that the cytosolic pool of catenins originates, at least in part, from the catenin molecules released from the complex with cadherin. Such catenin exchange, while suggested (Hinck et al., 1994; Bienz, 1999) , has never been directly demonstrated.
We showed that the pulse-labeled b-catenin immediately associates with cell surface-biotinylated E-cadherin. Since E-cadherin arrives at the plasma membrane approximately 30 min after synthesis already in a complex with b-catenin (Ozawa and Kemler, 1992; Hinck et al., 1994) , this observation suggests that 35 Slabeled b-catenin is substituted for its unlabeled counterpart associated with surface-located E-cadherin. This conclusion was further supported by the fact that the binding between 35 S-labeled b-catenin and biotinylated E-cadherin is independent of the time interval between biotinylation and pulse labeling. It excludes the possibility that this binding is caused by a minor pool of cadherin arriving at the plasma membrane in the catenin-free state. This binding is also independent of E-cadherin homodimerization. In addition, if the synthesis of the myc-tagged form of E-cadherin (Ec1 M) was induced when metabolic labeling had been terminated, the newly synthesized Ec1 M efficiently associated with 35 S-prelabeled b-catenin. Since a cytosolic (cadherin-free) pool of b-catenin able to interact with cadherin is very small (Gottardi et al., 2001) , this observation indicates that 35 S-labeled b-catenin was transferred from the endogenous E-cadherin to the Ec1M.
The high efficiency of the catenin exchange process became evident from the complex kinetics of association between the pulse-labeled b-catenin and the surfacelabeled E-cadherin. Phase 1, which lasts for 20-30 min, represents the direct substitution of 35 S-labeled b-catenin Approximately, 25% of all b-catenin molecules targeted for the complex with E-cadherin interact with this protein via this mechanism. After a 30-min chase, a sharp peak of b-catenin association with prebiotinylated E-cadherin was reproducibly observed. The appearance of this peak correlates with the arrival of pulse-labeled E-cadherin-catenin complexes to the plasma membrane. Therefore, we propose that this peak originates from the first round of b-catenin exchange between the Ecadherin molecules arriving at the plasma membrane and those that have been biotinylated on the cell surface.
The specific susceptibility of this peak to Brefeldin A supports this conclusion and furthermore suggests that this exchange may occur only at the plasma membrane. Considering the 3-4 fold increase in the amount of radiolabeled b-catenin in the complex with biotinylated E-cadherin after the 30-min chase and the fact that approximately 25% of radiolabeled b-catenin associates with biotinylated E-cadherin at time 0, one may propose that upon arrival at the plasma membrane, nearly all bcatenin was relocated immediately from the E-cadherin precursor to the prebiotinylated E-cadherin. As we showed recently, the extracellular portion of cadherin molecules continuously forms short-lived adhesive dimers, which apparently mediate cell-cell adhesion . Now we are showing that at the intracellular face the same molecules form short-lived complexes with catenins. It is possible that both these processes are functionally inter-related. The Trp156Ala mutation of E-cadherin, which abolishes cadherin dimerization, did not affect the catenin exchange process. This fact appears to exclude the direct dimerization dependency of the catenin exchange. Whether cadherin adhesive dimerization depends on catenin exchange needs to be tested. Each catenin exchange event may potentially provide energy for a conformational change within the extracellular Ecadherin region, which is needed for adhesive dimerization. The fact that adhesive dimerization requires catenins (Chitaev and Troyanovsky, 1998 ) is consistent with this idea.
The catenin exchange process may also play an important role in b-catenin-mediated signaling. An intriguing possibility is that the signaling activity of b-catenin is regulated within cell-cell junctions by adhesion-dependent post-translational modifications. b-Catenin is then released from the cadherin-catenin complex into the cytosol, becoming available for the signaling process. This simple mechanism may explain the suppressor effect of cadherin on Wnt signaling.
Another important question is the molecular mechanism of this exchange. Our attempts to elucidate this The catenin exchange using the protocol described in Figure 1a was studied in two APC-mutated colon adenocarcinoma cell lines, Colo 205 and HT-29. The cell lysates were split into two aliquots and precipitated either by streptavidin/Ecadherin (IP Streptavidin/E-cadherin) or with anti-b-catenin (IP bcatenin). The graphs show the quantitative measurements of b-catenin and a-catenin association with biotinylated E-cadherin. The data points represent averages from three separate experiments. Association of the corresponding proteins at 30 min in A-431 cells is assumed to be 100%. Note, the cells with APC mutations exhibit a normal exchange of acatenin, but the exchange of b-catenin and plakoglobin is strongly affected using different pharmacological inhibitors were unsuccessful. Neither the kinase nor actin polymerization inhibitors were able to compromise the exchange kinetics significantly. Therefore, reversible phosphorylation by most common protein kinases or dynamic association with microfilaments is unlikely to drive this process.
The C-terminal domain of plakoglobin or b-catenin competes by intramolecular interactions with cadherin for the cadherin-binding site present on the same molecule (Troyanovsky et al., 1996; Piedra et al., 2001) . These intramolecular interactions may facilitate the dynamic reassociation of b-catenin/plakoglobin with cadherin. Alternatively, APC, which also competes with cadherin for b-cadherin (Bienz, 1999) , might be implicated. Using its multiple catenin-binding sites, APC can facilitate the cadherin transfer from one to another catenin. The APC protein was found colocalized with adherens junctions (Rosin-Arbesfeld et al., 2001; McCartney et al., 2001) . Interestingly, the role of APC in the turnover of junctional b-catenin in insect cells was recently suggested by experiments with APC mutants (Hamada and Bienz, 2002) . The absence of the exchange in Colo 205 and HT-29 cells, both of which have mutations in the APC gene, suggests that APC may have some role in catenin exchange mechanism.
In summary, our data revealed a very efficient process: the exchange of catenins between E-cadherin molecules. This process may be an important factor in providing for the dynamic nature of cell-cell adhesion.
Materials and methods
Plasmid construction
To obtain the A-431 cells with inducible expression of the Ec1 M or Ec1WVM, the GeneSwitchtSystem (Invitrogen) was used. The HindIII/NotI-fragments encoding the Ec1M or Ec1WVM proteins (Chitaev and Troyanovsky, 1998) were excised from pRcCMV vectors and subcloned into the corresponding restriction sites of the pGene/V5-HisB vector. The resulting constructs (pG-Ec1 M or pG-Ec1WVM) were cotransfected with the pSwitch plasmid. Selective agents at a final concentration of 50 mg/ml for zeocin and 0.2 mg/ml for hygromycin B were added 72 h after transfection.
A full-size a-catenin cDNA in the pRcCMV vector (Invitrogen, Carlsbad, CA, USA) was cloned by RT-PCR from A-431 cell mRNA. All PCR-derived fragments were completely sequenced.
Cell cultures, DNA transfection, antibodies and immunoprecipitation
Transfection of A-431 cells, selection, growth and immunofluorescence microscopy have been described previously (Chitaev and Troyanovsky, 1998 The following mouse monoclonal antibodies were used: anti-E-cadherin, clone SHE 78-7, and antiplakoglobin, clone 11E4 (Zymed Laboratories, San Francisco, CA, USA); antimyc (clone 9E10, provided by Dr R Kopan, Washington University Medical School, St Louis, MO, USA); anti-flag M2 (Sigma, St Louis, MO, USA); anti-a-catenin, anti-E-cadherin (mAb C20820), and anti-b-catenin (Transduction Laboratories, Lexington, KY, USA).
Immunoprecipitation assay was described previously (Chitaev and Troyanovsky, 1998) .
Biotinylation of cell surface proteins and metabolic labeling
For pulse-labeling experiments, confluent cultures in 3 cm dishes were starved for 40 min in labeling medium (methionine/cysteine-free DMEM supplemented with 10% FCS dialyzed against PBS). The medium was removed and after washing with ice-cold PBS containing 0.2 mm CaCl 2 (PBS-C), cell surface proteins were labeled with 0.5 mg/ml of EZ-Linkt Sulfo-NHS-SS-Biotin (Pierce, Rockford, IL, USA) at room temperature for 10 min. The reaction was stopped by washing twice in ice-cold glycine solution (200 mm glycine/PBS-C, pH 7.4). Afterwards cells were pulse labeled with 60 mCi/ml [ 35 S]methionine/cysteine (Amersham, Piscataway, NJ, USA) for 10 min. Pulse labeling was stopped by double washing with ice-cold chase medium (DMEM supplemented with 10% FCS and 10 000-fold excess of cold methionine and cysteine). Then cells were chased in the same media. At the end of the chase periods, cells were extracted with the IP-buffer without DTT (IP-D) as above. The biotin-labeled proteins were precipitated with streptavidin-agarose (Sigma) for 1 h at 41C. Next, the biotinylated proteins were eluted from the beads by incubating with 150 ml of IP-buffer containing 200 mm DTT for 15 min at 371C. Supernatant was diluted with 850 ml of IP-D buffer, following by a regular immunoprecipitation as described above. The intensity of the 35 S-derived signals was quantified using the NIH Image program Version 1.62.
In some experiments, A-431 cells during biotinylation and pulse labeling were treated with different inhibitors. The inhibitors were added for the final 20 min during the starvation period, then the same inhibitor(s) were present in all cell media and solutions until the lyses. Inhibitors were used in the following concentration: Brefeldin A -5 mg/ml (Sigma); latrunculin A (Molecular Probes, Eugene, OR, USA) -4 nm; cytochalasin D (Sigma) -10 nm; H-7 (Sigma) -100 mg/ml; LiCl (Sigma) -2 mm; serine/threonine kinase inhibitor set containing staurosporine -100 mm; protein kinase G inhibitor -80 nm; M2-7 -1 nm; KN-93 -1 mm; H-89-dichloride -40 nm; bisindolylmaleimide I -400 nm; (Calbiochem, La Jolla, CA, USA); tyrosine kinase inhibitors set II containing genestein -20 mm; PP2 -3 mm; AG496 -6 mm; AG1296 -6 mm (Calbiochem).
The cells expressing mifepristone-inducible Ec1 M or Ec1WVM proteins were pulse labeled as above. After labeling and 20 min of chase period, the expression of the myc-tagged proteins were induced by adding mifepristone at a final concentration of 10 nm.
